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In 1972, the death penalty, as implemented, was found unconstitutional in Furman 
v. Georgia. The Supreme Court noted that the death penalty was imposed in such a 
haphazard manner that the Court considered it to be cruel and unusual punishment. 
Post-Furman, states reformulated their statutes to comply with the Court’s holding. 
In a series of cases, beginning with Gregg v. Georgia, the Supreme Court upheld 
the reformulated statutes, ushering in a new era for executions. 
 
In an attempt to make executions more humane, Oklahoma’s Department of Cor-
rections (“DOC”) consulted a physician to overhaul the state’s execution protocol. 
This consultation resulted in the implementation of the modern three-drug lethal 
injection cocktail.  
 
However, recent challenges to lethal injection protocols tell a different story. Euro-
pean-based drug companies, wary of having their products used in executions, have 
begun refusing to sell drugs to state DOCs. This refusal is mostly with respect to 
the first drug in the three-drug cocktail, the anesthetic. This refusal has led to drug 
shortages and improvisation that some doctors say will cause unnecessary pain and 
suffering during executions. In addition, shortages have increased the cost of these 
drugs. 
 
One solution to manufacturer-driven shortages is to open a pharmacy in every 
prison where executions are performed. This pharmacy could compound its own 
anesthetic. This procedure would ensure DOCs have the most appropriate drugs on 
hand, making executions both more humane and less costly. 
                                                          
* Heather Booth received her B.A. from American University in Washington, D.C. Heather is currently 
a J.D. candidate at the University of Missouri School of Law with an anticipated graduation date of May 
2019. The author would like to thank her family for all of their support throughout her law school career, 
and the members of the Missouri Business, Entrepreneurship & Tax Law Review for their assistance. 
Special thanks to Ben Kweskin for his encouragement and unending patience. 
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I. INTRODUCTION 
On July 23, 2014, Joseph Wood was put to death by lethal injection.1 His death 
took two hours.2 He was injected with lethal chemicals 15 times.3 During the exe-
cution, Wood “spent an hour of his execution ‘gasping and snorting.’”4 This sce-
nario has become more common across the country as historic drugs-of-choice have 
become unavailable, and states have transitioned to unproven alternatives.5 While 
the death penalty itself has been declared constitutional, the Supreme Court has not 
specifically weighed in on an appropriate method of administration by which to 
avoid “cruel and unusual punishment.”6 
As of February 2017, 12 states statutorily prohibit the dissemination of infor-
mation relating to its supplies of lethal injection drugs.7 Shielding the identity of the 
drug supplier might make it easier for states to obtain the drugs necessary to admin-
ister the death penalty, mostly due to the manufacturers’ wish to not be associated 
with the death penalty.8 However, shielding the identity of the supplier can affect 
accountability by shielding state policy from judicial review.9 This article argues 
that if we, as a nation, are going to execute in the name of the state, we should do it 
                                                          
 1. Adam Serwer, Lethal Drugs Injected 15 Times in Botched Arizona Execution, MSNBC, 
http://www.msnbc.com/msnbc/lethal-drugs-injected-15-times-botched-arizona-execution (last updated 
Aug. 4, 2014, 9:27 AM). 
 2. Arizona Department of Corrections Correctional Service Log, DEATH PENALTY INFO. CTR., 
https://deathpenaltyinfo.org/documents/JosephWoodExecutionLog.pdf (last visited Nov. 21, 2018) 
[hereinafter Execution Log]. 
 3. Id.; Serwer, supra note 1. 
 4. Serwer, supra note 1. 
 5. See, e.g., Jeffrey E. Stern, The Cruel and Unusual Execution of Clayton Lockett, ATLANTIC (June 
2015), https://www.theatlantic.com/magazine/archive/2015/06/execution-clayton-lockett/392069/; 
N.L., How America Botches Executions Using Lethal Injections, ECONOMIST (Aug. 24, 2017), 
https://www.economist.com/blogs/economist-explains/2017/08/economist-explains-23; Ben Crair, 
2014 is Already the Worst Year in the History of Lethal Injection, NEW REPUBLIC (July 23, 2014), 
https://newrepublic.com/article/118833/2014-botched-executions-worst-year-lethal-injection-history; 
Botched Executions, DEATH PENALTY INFO. CTR. (2016), https://deathpenaltyinfo.org/some-examples-
post-furman-botched-executions. 
 6. See U.S. CONST. amend. VIII; Glossip v. Gross, 135 S. Ct. 2726, 2737 (2015); Baze v. Rees, 553 
U.S. 35, 56–57 (2008). 
 7. While several states have statutes prohibiting the release of information relating to the administra-
tion of lethal injection, some states have merely refused to provide information in response to requests. 
See ARIZ. REV. STAT. ANN. § 13-757(C) (2009); MISS. CODE ANN. § 99-19-51(6)(c), (7) (2017); MO. 
REV. STAT. § 546.720(2) (2007); Tom Dart et al., Secret America: How States Hide the Source of Their 
Lethal Injection Drugs, GUARDIAN (May 15, 2014), https://www.theguardian.com/world/ng-interac-
tive/2014/may/15/-sp-secret-america-lethal-injection-drugs; State by State Lethal Injection, DEATH 
PENALTY INFO. CTR., https://deathpenaltyinfo.org/state-lethal-injection (last visited Nov. 21, 2018) 
[hereinafter State by State]; Informal Op. Del. Att’y Gen. 13-IB07 (2013), 2013 Del. AG LEXIS 10; 
Through the Glass Darkly: What Oklahoma’s Lethal Injection Regime Tells Us about Secrecy, Incom-




 8. See Eric Berger, Lethal Injection Secrecy and Eighth Amendment Due Process, 55 B.C. L. REV. 
1367, 1372 (2014); Lincoln Caplan, The End of the Open Market for Lethal Injection Drugs, NEW 
YORKER (May 21, 2016), https://www.newyorker.com/news/news-desk/the-end-of-the-open-market-
for-lethal-injection-drugs [hereinafter L. Caplan]. 
 9. Id. 
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correctly—and in the most humane manner possible—every time.10 In order to 
achieve that goal, American DOCs either need assistance from both pharmacists 
and foreign based drug manufacturers, or to proceed in a new direction entirely. 
Part II of this article will provide a discussion of the history of lethal injection 
post-Furman.11 Part III will discuss the reasons behind the shortage of lethal injec-
tion drugs. Part IV will examine state responses to those shortages. Part V will con-
sider the lessons for states stemming from the “Death with Dignity” movement and 
how states can use compounding12 to meet the goal of humane executions. Finally, 
Part VI will address possible actions that states can take to ensure the most effective 
drugs are available for the administration of lethal injection. 
II. LEGAL HISTORY OF LETHAL INJECTION 
A. Furman and Gregg Reformulate the Death Penalty 
In 1972, the Supreme Court held the death penalty, as then administered, to be 
unconstitutional.13 This ruling came as a result of a consolidated case,14 later known 
as Furman v. Georgia.15 In Furman, three defendants alleged that the punishment 
of death handed down in their cases constituted cruel and unusual punishment in 
violation of the Eighth and Fourteenth Amendments.16 The  Court agreed.17 In a per 
curiam opinion, the Court held that the death penalty, as administered by the states 
of Georgia and Texas, was unconstitutional.18 The majority of the Justices opined 
that the death penalty was being imposed by these states in an arbitrary and capri-
cious manner because it was haphazard.19 Justice Stewart specifically stated that 
this sort of random imposition of the death penalty “[is] cruel and unusual in the 
same way that being struck by lightning is cruel and unusual.”20 Moreover, Justice 
                                                          
 10. Discussion of the death penalty’s appropriateness as a punishment, and issues regarding its impo-
sition, are outside the scope of this article. 
 11. Furman v. Georgia, 408 U.S. 238, 239 (1972) (per curiam). 
 12. See, e.g., Compounding and the FDA: Questions and Answers, FDA, 
https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompound-
ing/ucm339764.htm [hereinafter Compounding and the FDA] (last updated June 22, 2018) (compound-
ing is “the process of combining, mixing, or altering ingredients to create a medication tailored to the 
needs of an individual patient.”). 
 13. Gregg, 408 U.S. at 239–40 (holding that the imposition of the death penalty in Georgia violated 
the Eighth and Fourteenth Amendments). 
 14. The cases consolidated under the umbrella of Furman also include actions brought by Lucious 
Jackson against the State of Georgia and Elmer Branch against the State of Texas. Furman, Jackson, and 
Branch were all sentenced to death after their convictions; however, Furman was the only one of the 
defendants whose crime included the murder of his victim. Branch and Jackson were convicted of rape. 
Id. at 252–53; Jackson v. State, 171 S.E.2d 501, 503 (Ga. 1969); Branch v. State, 447 S.W.2d 932, 933 
(Tex. Crim. App. 1969). 
 15. Furman, 408 U.S. at 238. 
 16. Id. at 239. 
 17. Id. at 239–40. 
 18. Id. at 239 (none of the Justices in the majority joined in the opinion of any other Justice. Justices 
Brennan and Marshall believed the death penalty to be cruel and unusual punishment and not comporting 
with the standards of evolving decency. All four dissenting Justices joined in one opinion). 
 19. Id. at 310 (Stewart, J., concurring) (finding the death penalty to have been “wantonly and freak-
ishly imposed”); see also William Cody Newsome, Note & Comment, A Promise Unfulfilled: Chal-
lenges to Georgia’s Death Penalty Statute Post-Furman, 33 GA. ST. U. L. REV. 839, 839 (2017). 
 20. Furman, 408 U.S. at 310 (Stewart, J., concurring). 
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White determined that, given how infrequently the death penalty was actually car-
ried out, it could not satisfy any rationale for punishment.21 
This ruling, in addition to reversing the three death sentences at the center of 
this case, “invalidat[ed] death penalty statutes in approximately 40 states and over-
turn[ed] 600 death penalty sentences.”22 The main issue in all capital jurisdictions 
was unbridled jury discretion in the imposition of the death penalty.23 Prior to the 
Court’s decision in Furman, every capital jurisdiction in the country determined a 
death sentence solely in a unitary trial format.24 This was problematic for many 
reasons, most notably because of the lack of mitigating evidence presented at such 
trials.25 Defendants in capital cases were reluctant to introduce such evidence during 
trial “for fear that a jury might regard such evidence as an indirect admission of 
guilt.”26 Additionally, juries were “death qualified,” meaning any jurors who re-
fused to consider death for a guilty defendant would have been excluded.27 
American support for the death penalty began to decline in the late 1960s.28 In 
1966, fewer Americans supported the death penalty than opposed it.29 Once Furman 
abrogated the death penalty in all jurisdictions, some were of the opinion that new 
laws would not be written and the death penalty would die out.30 Even the Justices 
themselves believed the death penalty had seen its last day. Justice Stewart report-
edly informed his clerks that “the death penalty in America was finished.”31 Justice 
Burger, who had dissented in Furman, believed that America had seen its last exe-
cution.32 However, this was not the case. 
Although public sentiment went against the death penalty, the confluence of 
several factors ensured its resurgence. First, Furman only held state statutes uncon-
stitutional by a slim majority.33 Not only was the case decided by a 5-4 margin, not 
one of the Justices in the majority joined in an opinion with any of the others.34 
Second, because there were six separate opinions (the five in the majority plus the 
dissent), there was no clear singular holding.35 Because only Justices Brennan and 
Marshall held the death penalty unconstitutional on its face, the door was left open 
for states to attempt to meet the requirements espoused in Furman—namely, to 
                                                          
 21. Id. at 311–12 (White, J., concurring). 
 22. Robert A. Stein, The History and Future of Capital Punishment in the United States, 54 SAN 
DIEGO L. REV. 1, 12 (2017). 
 23. CAROL S. STEIKER & JORDAN M. STEIKER, COURTING DEATH 43 (2016). 
 24. Id. 
 25. Id. at 44–45. 
 26. Id. (mitigating evidence is, by definition, culpability reducing. To introduce such evidence during 
trial would be akin to stating, “I did it, but I should not be put to death because I am not as culpable as 
the evidence makes me out to be.”). 
 27. Id. at 45. 
 28. Jeffrey M. Jones, U.S. Death Penalty Support at 60%, GALLUP (Oct. 25, 2016), http://news.gal-
lup.com/poll/196676/death-penalty-support.aspx. 
 29. Id. (according to polling, 47% of Americans were against the death penalty while 42% were in 
favor). 
 30. See Barry Schweid, New Laws Unlikely on Death Penalty, FREE LANCE-STAR (June 30, 1972), 
https://news.google.com/newspapers?id=pAoQAAAAIBAJ&sjid=2YoDAAAAI-
BAJ&pg=3786,38609&hl=en. 
 31. EVAN J. MANDERY, A WILD JUSTICE: THE DEATH AND RESURRECTION OF CAPITAL PUNISHMENT 
IN AMERICA 242 (2013). 
 32. Id. 
 33. Furman v. Georgia, 408 U.S. 238, 238 (1972). 
 34. Id. at 240. 
 35.  STEIKER & STEIKER, supra note 23, at 60. 
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check the jury’s unbridled discretion and to make the imposition of death less arbi-
trary and capricious.36 
Third, in addition to the confusion caused by the various opinions in Furman, 
public officials opposed the holding. President Nixon, in 1973, openly called for a 
return of the death penalty for federal crimes.37 Georgia Governor Lester Maddox 
publicly stated that the Court’s decision in Furman was a “license for anarchy, rape, 
and murder.”38 This was enough to turn the tide of American sentiment, and begin-
ning in 1972, there was a fresh surge of support for the death penalty.39 
In response to Furman and public anti-abolitionist sentiment, death penalty 
states, including Georgia, overhauled their statutes and reenacted legislation in or-
der to resume imposing death sentences.40 Just six months after the Court’s decision 
in Furman, Florida became the first of many states to reinstate the death penalty.41 
Thirty-five states in total enacted new laws to comply with the Court’s directives.42 
Seven states enacted laws that held a mandatory death sentence for any murder con-
viction.43 While the remaining states still retained some jury discretion, that discre-
tion was limited by statutory guidance.44 
In 1962, the American Legal Institute recommended the Model Penal Code 
(“MPC”).45 The Council, after some hesitation, included § 210.6, “Sentence of 
Death for Murder; Further Proceedings to Determine Sentence.”46 Although this 
section has since been withdrawn,47 it was the blueprint many states used when 
reformulating their capital punishment statutes.48 The MPC provided that capital 
punishment was only available for first-degree murder in which the fact-finder 
                                                          
 36. Furman, 408 U.S. at 290, 369 (Justice Brennan wrote that the death penalty was inconsistent with 
the concept of human dignity. “Death is truly an awesome punishment. The calculated killing of a human 
being by the State involves, by its very nature, a denial of the executed person’s humanity.” Justice 
Marshall opined that, if the public possessed all of the available information regarding the death penalty, 
they would “find it shocking to his conscience and sense of justice.”). 
 37. Richard Nixon, Radio Address About the State of the Union Message on Law Enforcement and 
Drug Abuse Prevention, AM. PRESIDENCY PROJECT (Mar. 10, 1973), https://www.presi-
dency.ucsb.edu/node/256179 (proposing a statute establishing the death penalty for federal crimes of 
“murder[,] treason and other war-related crimes”). 
 38. JEFFREY L. KIRCHMEIER, IMPRISONED BY THE PAST: WARREN MCCLESKEY AND THE AMERICAN 
DEATH PENALTY 94 (2015). 
 39. Jones, supra note 28 (stating that, in 1972, 57% of Americans supported the death penalty). 
 40. Stein, supra note 22, at 12. 
 41. Florida Becomes First to Reinstate the Death Penalty, N.Y. TIMES (Dec. 9, 1972), http://www.ny-
times.com/1972/12/09/archives/florida-becomes-first-to-reinstate-the-death-penalty.html. Florida’s 
statute bifurcated the trial into a guilt phase and a sentencing phase. During the guilt phase, a jury decided 
liability and would then recommend either death or life in prison. The trial judge then had complete 
discretion to determine the fate of defendant, even if it meant overruling the jury’s recommendation. 
 42. STEIKER & STEIKER, supra note 23, at 61. 
 43. See, e.g., id. at 62. These statutes mandating death for guilty defendants would later be overruled 
by Woodson v. North Carolina, 428 U.S. 280 (1976) and Roberts v. Louisiana, 428 U.S. 325 (1976). 
 44. STEIKER & STEIKER, supra note 23, at 62. 
 45. A.L.I., REPORT OF THE COUNCIL TO THE MEMBERSHIP OF THE AMERICAN LAW INSTITUTE ON 
THE MATTER OF THE DEATH PENALTY 1–2 (2009), https://deathpenaltyinfo.org/documents/alicoun.pdf 
[hereinafter ALI Report]. 
 46. MODEL PENAL CODE § 210.6 (A.L.I., withdrawn 2009); ALI REPORT, supra note 45, at 2. 
 47. See ALI REPORT, supra note 45. 
 48. See STEIKER & STEIKER, supra note 23, at 61. 
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found at least one aggravating circumstance, and that aggravating circumstance out-
weighed any mitigating circumstances.49 Additionally, the MPC espoused a bifur-
cated trial with a guilt phase followed by a sentencing phase.50 Proceeding in this 
manner would allow defendants to submit evidence of mitigating factors to the jury 
without worry of implicit acknowledgement of guilt.51 
The Court had the opportunity to review the new slate of state statutes in Gregg 
v. Georgia.52 Troy Gregg was charged with robbery and murder by the state of 
Georgia and sentenced to death.53 Georgia’s new capital punishment system, refor-
mulated post-Furman, required a bifurcated trial.54 The liability or guilt phase re-
mained the same as in any other trial; the change arose in the sentencing phase.55 
The new sentencing scheme allowed “substantial latitude as to the types of evidence 
that [the defendant could] introduce.”56 Moreover, prior to a jury handing down a 
death sentence, they “must find beyond a reasonable doubt one of the ten aggravat-
ing circumstances specified in the statute,” and they must then specify that factor 
when they impose sentence.57 Further, the jury’s recommended sentence was bind-
ing on the judge.58 Ultimately, any death sentence handed down in a trial court was 
automatically appealed to the Georgia Supreme Court.59 
In a plurality opinion, the Gregg Court held that the newly-reenacted statutory 
scheme did not violate either the Eighth or the Fourteenth Amendment, clearing the 
way for death sentences to be carried out across the country.60 The same could not 
be said of the states with mandatory death sentences for murder convictions.61 
While the Court did not explicitly strike down mandatory death sentences in Gregg, 
the Court strongly implied that individualized determinations were required.62 The 
Court later explicitly struck down statutes requiring mandatory death sentences.63 
                                                          
 49. MODEL PENAL CODE § 210.6 (listing eight aggravating circumstances and eight mitigating cir-
cumstances). 
 50. Id. 
 51. See STEIKER & STEIKER, supra note 23, at 44–45. 
 52. Gregg v. Georgia, 428 U.S. 153 (1976). 
 53. Id. at 158. 
 54. Id. at 163 (retaining capital punishment for murder, rape, armed robbery, aircraft hijacking, trea-
son, and kidnapping for ransom or resulting in harm to the victim). 
 55. Id. at 163–66. 
 56. Id. at 164. 
 57. Id. at 164–65. The jury is not required to find the presence of an aggravating factor in cases of 
airline hijacking. 
 58. Id. at 166. 
 59. Id. at 198. 
 60. Id. at 207. Later cases restricted capital punishment to specific crimes and prohibited for certain 
types of defendants. See Coker v. Georgia, 433 U.S. 584, 599 (1977) (requiring death of the victim in 
addition to aggravating circumstances in order to inflict capital punishment on defendant); Ford v. Wain-
wright, 477 U.S. 399, 408 (1986) (holding the Eighth Amendment insulates the insane from capital pun-
ishment); Atkins v. Virginia, 536 U.S. 304, 321 (2002) (holding that the mentally handicapped cannot 
be sentenced to death); Roper v. Simmons, 543 U.S. 551, 575 (2005) (prohibiting the death penalty for 
juveniles). 
 61. See Gregg, 428 U.S. at 180–81. 
 62. Id. at 206. 
 63. Sumner v. Shuman, 483 U.S. 66, 85 (1987). 
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B. Post-Gregg Lethal Injection 
After Gregg affirmed the constitutionality of the death penalty, states resumed 
executions.64 In 1977, a medical examiner from Oklahoma proposed the modern, 
three-drug cocktail for lethal injection: a barbiturate to anesthetize the inmate; a 
paralytic agent to immobilize him; and potassium to stop the heart.65 Oklahoma’s 
legislature adopted this as the official method of executions.66 Texas followed suit 
just one day later.67 On December 7, 1982, Texas became the first state to execute 
an inmate by lethal injection.68 Currently, 33 states have statutes approving lethal 
injection as the primary method of execution.69 Eight states have carried out lethal 
injections using a single dose of anesthetic.70 Since 1976, there have been 1,473 
executions—1,298 by lethal injection.71 
While the method of execution is consistent across those 33 states, the protocol 
varies from state to state.72 Deviation from the original three-drug cocktail of so-
dium thiopental (“thiopental”), pancuronium bromide (“pancuronium”), and potas-
sium chloride has become more common as the availability of these chemicals has 
decreased.73 This decrease is due in large part to European based drug manufactur-
ers’ refusal to provide these pharmaceuticals to departments of corrections 
                                                          
 64. See Part I: History of the Death Penalty: Introduction to the Death Penalty, DEATH PENALTY 
INFO. CTR., https://deathpenaltyinfo.org/part-i-history-death-penalty (last visited Nov. 21, 2018). Utah 
became the first state to execute a condemned prisoner with the January 17, 1977 execution of Gary 
Gilmore by firing squad. Lily Rothman, The Strange Story of the Man Who Chose Execution by Firing 
Squad, TIME (Mar. 12, 2015), http://time.com/3742999/gary-gilmore-history/. 
 65. See So Long as They Die: Lethal Injections in the United States, 18 HUM. RTS. WATCH 13–15 
(Apr. 2006), https://www.hrw.org/reports/2006/us0406/us0406webwcover.pdf; Ty Alper, The Ignoble 
History of the 3-Drug Death Penalty Cocktail, L.A. TIMES (Apr. 20, 2017, 4:00 AM), 
http://www.latimes.com/opinion/op-ed/la-oe-alper-3-drug-cocktail-20170420-story.html. While an ap-
propriate dose of the barbiturate should be sufficient to render the inmate completely unconscious for 
the duration of the procedure, the paralytic agent is still included in order to minimize the inmate’s visible 
reaction to the potassium, making the execution less stressful for the witnesses to watch. Id.; Kate Pick-
ert, A Brief History of Lethal Injection, TIME (Nov. 10, 2009), http://content.time.com/time/nation/arti-
cle/0,8599,1815535,00.html. 
 66. Alper, supra note 65; OKLA. STAT. tit. 22, § 1014 (2017). 
 67. TEX. CODE CRIM. PROC. ANN. art. 43.14 (West 2015). 
 68. Death Row Information, TEX. DEPT. CRIM. JUST., 
http://www.tdcj.state.tx.us/death_row/dr_facts.html (last visited Nov. 21, 2018). Charlie Brooks was ex-
ecuted via administration of sodium thiopental as the barbiturate, pancuronium bromide (brand name 
Pavulon) to paralyze, and potassium chloride to stop the heart. Brooks was pronounced dead seven 
minutes after the initial injection of sodium thiopental. Convicted Killer Executed by Injection, 
ELLENSBURG DAILY REC., Dec. 7, 1982, at 11, https://news.google.com/newspapers?id 
=xZZUAAAAIBAJ&sjid=T48DAAAAIBAJ&pg=6595%2C6716686. 
 69. Methods of Execution, DEATH PENALTY INFO. CTR., https://deathpenaltyinfo.org/methods-execu-
tion (last visited Nov. 21, 2018) [hereinafter Methods]. Several states have alternate methods of execu-
tion available by statute in case lethal injection chemicals are not available or lethal injection be declared 
unconstitutional. See, e.g., OKLA. STAT. ANN. tit. 22, § 1014 (West 2017) (providing that, should lethal 
injection be deemed unconstitutional, execution shall be administered via gas chamber, electrocution, or 
firing squad). 
 70. State by State, supra note 7 (indicating that the states that have executed using only a single drug 
have either used pentobarbital or sodium thiopental). 
 71. Methods, supra note 69. These numbers include executions up to and including April 19, 2018. 
 72. See State by State, supra note 7. 
 73. See Jennifer Horne, Lethal Injection Drug Shortage, COUNCIL OF ST. GOV’TS (July & Aug. 2017), 
https://www.csg.org/pubs/capitolideas/enews/issue65_4.aspx (discussing the need to change drug pro-
tocols due to drug shortages that occurred when Hospira ceased manufacturing sodium thiopental in the 
United States). 
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(“DOC”).74 In response to the decreased availability of thiopental, many states 
switched to using pentobarbital as the barbiturate of choice.75 However, drug man-
ufacturers, mostly based in Europe, have placed distribution controls on drugs that 
are commonly used in executions.76 This has left states scrambling to find new—
and untested—drugs to use for lethal injection protocols. For example, Florida ex-
ecuted Mark Asay using a combination of etomidate to anesthetize, rocuronium 
bromide to paralyze, and potassium acetate to stop the heart.77 This execution pro-
tocol is particularly concerning because etomidate was never before used in an ex-
ecution, and potassium acetate was only used before on accident.78 
Due to the shortage of pentobarbital,79 many states have moved to administer-
ing midazolam as the first drug in the three-drug cocktail.80 Midazolam differs from 
the traditionally used anesthetic pharmaceuticals in that it is a sedative used for short 
term procedures, which results in the patient having little to no memory of the pro-
cedure.81 However, it does not produce a deep anesthesia such as traditional anes-
thetic agents do.82 Although controversial, the Court held that the use of midazolam 
in executions does not violate the Eighth Amendment’s prohibition of cruel and 
unusual punishment because “the prisoners failed to establish that Oklahoma’s use 
of a massive dose of midazolam in its execution protocol entails a substantial risk 
of severe pain.”83 
Critics of these new lethal injection protocols have argued that these new com-
binations of drugs are untested and unproven.84 Additionally, some have called the 
use of these untested protocols akin to human experimentation—an assertion which, 
                                                          
 74. L. Caplan, supra note 8. 
 75. State by State, supra note 7. 
 76. Ed Pilkington, Europe Moves to Block Trade in Medical Drugs Used in US Executions, GUARDIAN 
(Dec. 20, 2011, 1:27 PM), https://www.theguardian.com/world/2011/dec/20/death-penalty-drugs-euro-
pean-commission. 
 77. Katie Mettler, A Death Penalty Landmark for Florida: Executing a White Man for Killing a Black 
Man, WASH. POST (Aug. 24, 2017), https://www.washingtonpost.com/news/morning-
mix/wp/2017/08/24/a-death-penalty-first-for-florida-executing-a-white-man-for-killing-a-black-man/. 
 78. Id.; Associated Press, Florida Executes Man with Drug Never Used in Lethal Injection, GUARDIAN 
(Aug. 24, 2017, 7:53 PM), https://www.theguardian.com/us-news/2017/aug/24/florida-execution-mark-
asay-anesthetic-etomidate. Asay was pronounced dead eleven minutes after the execution began. News 
Service of Florida, Florida Executes Convicted Killer Mark Asay Using New Drug, ORLANDO SENTINEL 
(Aug. 24, 2017, 7:40 PM), https://www.orlandosentinel.com/news/crime/os-execution-florida-asay-
20170824-story.html. 
 79. Pentobarbital has become the barbiturate of choice after the supplies of thiopental dried up. See 
discussion infra Section III.B. 
 80. See Mark Berman, Texas is About to Run out of Lethal Injection Drugs, WASH. POST (Mar. 10, 
2015), https://www.washingtonpost.com/news/post-nation/wp/2015/03/10/texas-is-about-to-run-out-
of-lethal-injection-drugs/?noredirect=on&utm_term=.0ad8333533fd. Midazolam has been roundly crit-
icized as putting “prisoners at risk of an unconstitutionally painful punishment” after use in executions 
in Oklahoma, Ohio, Arizona, and Alabama seemingly left inmates in agony for prolonged periods. Alan 
Blinder, When a Common Sedative Becomes an Execution Drug, N.Y. TIMES (Mar. 13, 2017), 
https://www.nytimes.com/2017/03/13/us/midazolam-death-penalty-arkansas.html. Additionally, mid-
azolam cannot create “the deep, coma-like state needed to guarantee [the inmate] feels no pain.” Stern, 
supra note 5. 
 81. Glossip v. Gross, 135 S. Ct. 2726, 2783 (2015). 
 82. Id. 
 83. Id. at 2731. 
 84. See Editorial, State-Sponsored Horror in Oklahoma, N.Y. TIMES (Apr. 30, 2014), https://www.ny-
times.com/2014/05/01/opinion/state-sponsored-horror-in-oklahoma.html. 
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if true, implicates a whole spate of other regulatory issues.85 One Florida Supreme 
Court Justice went so far as to call Assay, the inmate executed by injection of etomi-
date, “the proverbial guinea pig of [Florida’s] newest lethal injection protocol.”86 
Moreover, some physicians have stated the current three-drug protocol is so inhu-
mane, due in large part to the paralytic component, that it has been deemed inap-
propriate even in animal euthanasia.87 
The Court’s decisions in Furman,88 Gregg,89 Glossip,90 and Baze91 caused 
states to reformulate death penalty statutes to follow the Court’s directives. Cur-
rently, state statutes overwhelmingly prefer lethal injection;92 however, those stat-
utes are becoming increasingly difficult to implement given the shortage of lethal 
injection pharmaceuticals. 
III. THE SHORTAGE OF LETHAL INJECTION PHARMACEUTICALS 
A. Sodium Thiopental 
Until 2011, the anesthetic of choice for lethal injections was thiopental.93 How-
ever, this changed as the supply of thiopental dwindled.94 Hospira, the only Amer-
ican manufacturer of thiopental, ceased production in 2009 after citing quality con-
trol issues.95 While Hospira planned to resume production at a plant in Italy, those 
plans became unworkable as Hospira was “unwilling to take on the liability risk 
after government officials in Italy demanded the company ‘control the product all 
the way to the ultimate end user to prevent use in capital punishment.’”96 Hospira 
decided not to risk it and exited the thiopental market altogether.97 
                                                          
 85. 45 C.F.R. § 46.306 (2001); Ed Pilkington, Lawyers Fight to Halt Ohio Execution Condemned as 
Human Experimentation, GUARDIAN (Dec. 7, 2009, 3:02 PM), https://www.theguard-
ian.com/world/2009/dec/07/lawyers-fight-ohio-execution; Arthur L. Caplan, Does Execution by Lethal 
Injection Violate the Ethics of Human Research?, BIOETHICS.NET (Nov. 15, 2013), http://www.bioeth-
ics.net/2013/11/does-execution-by-lethal-injection-violate-the-ethics-of-human-research/ [hereinafter 
A. Caplan]; U.S. DEP’T OF HEALTH AND HUMAN SERVICES OFF. FOR HUMAN RESEARCH PROTS., 
PRISONER INVOLVEMENT IN RESEARCH (2003), https://www.hhs.gov/ohrp/regulations-and-policy/guid-
ance/prisoner-research-ohrp-guidance-2003/index.html; L. Caplan, supra note 8. 
 86. Asay v. State, 224 So.3d 695, 704 (Fla. 2017) (Pariente, J., dissenting). Florida executed Asay 
using the new etomidate protocol on August 24, 2017. Mark Berman, Using a New Drug, Florida Exe-
cutes a Death-Row Inmate for the First Time in a Year-and-a-Half, WASH. POST (Aug. 24, 2017), 
https://www.washingtonpost.com/news/post-nation/wp/2017/08/24/florida-prepares-to-execute-a-
death-row-inmate-for-the-first-time-in-a-year-and-a-half/?utm_term=.04008afa8da1. 
 87. Leonidas G. Koniaris, Teresa A. Zimmers, David A. Lubarsky & Jonathan P. Sheldon, Inadequate 
Anesthesia in Lethal Injection for Execution, 365 LANCET 1412, 1414 (2005). 
 88. 408 U.S. 238 (1972) (per curiam). 
 89. 428 U.S. 153 (1976). 
 90. 135 S. Ct. 2726 (2015). 
 91. 553 U.S. 35 (2008). 
 92. See Methods, supra note 69. 
 93. See State by State, supra note 7; Horne, supra note 73. 
 94. Horne, supra note 73 (detailing the need to change drug protocols due to drug shortages that oc-
curred with Hospira ceased manufacturing sodium thiopental in the United States). 
 95. Cook v. FDA, 733 F.3d 1, 4 (D.C. Cir. 2013); Bruce Jaspen, Hospira Ceases Production of Anes-
thetic Used in Executions, CHI. TRIB. (Jan. 21, 2011), https://www.chicagotribune.com/business/ct-xpm-
2011-01-21-ct-biz-0122-execution-drug-20110121-story.html. 
 96. Jaspen, supra note 95. 
 97. Id. 
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Thiopental’s use in the United States predated the implementation of the Food, 
Drug, and Cosmetic Act (“FDCA”) of 1938 and, therefore, has never been approved 
by the Food and Drug Administration (“FDA”) for importation.98 It is “unlawful to 
introduce into interstate commerce a misbranded drug, or an unapproved new drug” 
under the terms of the FDCA.99 Drugs are considered misbranded if they are im-
ported by a manufacturer not currently registered with the FDA.100 
All new drugs101 must pass a rigorous FDA application process, or, in the al-
ternative, must satisfy two requirements.102 The first requirement is that the drug 
must have been shown to be “generally recognized . . . as safe and effective for use 
under the conditions prescribed, recommended, or suggested” on the label.103 Sec-
ond, even supposing that the drug has been shown to be “[generally recognized as 
safe and effective] as a ‘result of investigations to determine its safety and effec-
tiveness for use under such conditions,’” it is still considered a new drug unless it 
has been in use in conditions other than the investigative process “to a material 
extent or for a material time under such conditions.”104 These regulations have been 
implemented to ensure that drugs entering the United States from foreign wholesal-
ers and distributors meet a certain safety standard.105 
So long as Hospira continued to manufacture thiopental in the United States, 
these statutes were not implicated.106 However, in 2011, when Hospira ceased pro-
duction, there were no remaining manufacturers located in the United States.107 As 
the supply of thiopental disappeared in the United States, some states attempted to 
import the drug from less than reputable sources. 
Several states ordered a supply of the drug from a British based distributor 
known as Dream Pharma.108 Dream Pharma obtained the finished thiopental it sold 
to American DOCs from Archimedes Pharma UK, Ltd., who obtained unfinished 
                                                          
 98. See Matthew Gunther, Sodium Thiopental, CHEMISTRY WORLD (Mar. 11, 2015), 
https://www.chemistryworld.com/podcasts/sodium-thiopental/8360.article. Sodium Thiopental was first 
discovered in the late 1930s and was first used as an anesthetic on humans in 1934. Cook, 733 F.3d at 4. 
 99. 21 U.S.C. § 331(a) (2018); Cook, 733 F.3d at 3. 
 100. Id. § 352(o) (2018). 
 101. Id. § 355(a) (2018). Any drug introduced into interstate commerce without having first been ap-
proved by the FDA is considered an unapproved new drug. 
 102. See id. § 355(b). 
 103. Id. § 321(p)(1) (2016). 
 104. Id. § 321(p)(2) (2009); E-mail from Todd W. Cato, FDA Dir., Sw. Imp. Dist. Office, at 11 (Apr. 
20, 2017), https://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOper-
ationsandPolicy/ORA/ORAElectronicReadingRoom/UCM555237.pdf (internal quotations and citations 
omitted) [hereinafter Cato Letter]; U.S. v. Premo Pharm. Labs., Inc., 511 F. Supp. 958, 976 (D.N.J. 1981) 
(stating that the decision as to whether a drug has been used to a material extent or for a medical time is 
subject to determination by the FDA). 
 105. See PETER BARTON HUTT, RICHARD A. MERRILL & LEWIS A. GROSSMAN, FOOD & DRUG LAW: 
CASES & MATERIALS 1439 (4th ed. 2014). 
 106. See Cato Letter, supra note 104, at 11 n.13. 
 107. Press Release, Hospira, Hospira Statement Regarding Pentothal™ (sodium thiopental) Market 
Exit (Jan. 21, 2011), http://phx.corporate-ir.net/phoenix.zhtml?c=175550&p=irol-newsAr-
ticle&ID=1518610&highlight=Pentothal. 
 108. L. Caplan, supra note 8; Owen Bowcott, London Firm Supplied Drugs for US Executions, 
GUARDIAN (Jan. 6, 2011, 12:45 PM), https://www.theguardian.com/world/2011/jan/06/london-firm-
supplied-drugs-us-executions. Dream Pharma was a licensed pharmaceutical wholesaler despite being 
run out of the back of a driving school in London. 
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thiopental from Sandoz.109 None of these parties were registered with the FDA or 
authorized to distribute thiopental to any purchaser in the United States.110 
In Cook v. Food and Drug Administration, the United States Court of Appeals 
for the District of Columbia Circuit decided whether the FDA had discretion to 
ignore statutory requirements to seize and test any drug shipments from unregis-
tered distributors entering the United States.111 Several death row prisoners brought 
suit against the FDA after the FDA publicly stated that it would not be reviewing 
shipments of thiopental sent to states’ DOCs.112 The FDA further stated it would be 
deferring to the determinations of local law enforcement agencies.113 
The plaintiffs alleged that the FDA’s statement violated the Administrative 
Procedure Act (“APA”) in that the FDA’s decision was not in accordance with the 
FDCA.114 The FDA argued that it had discretion whether to review imported ship-
ments of thiopental, while the plaintiffs argued that the FDA was bound by the 
FDCA to refuse admission to any drug shipment that did not meet statutory require-
ments.115 The district court entered summary judgment on behalf of the plaintiffs in 
this case, and, in a separate order, “permanently enjoined the FDA from permitting 
the entry of, or releasing any future shipments of, foreign manufactured thiopental 
that appears to be misbranded or an unapproved new drug.”116 Further, the district 
court required the state’s DOC to return the thiopental in its possession as “the use 
of such [foreign manufactured thiopental] is prohibited by law.”117 
The relevant statutory language provides that if imported drugs are from an 
establishment not registered with the FDA, samples of the drugs must be sent to the 
Secretary of Health and Human Services for review.118 Additionally, “[i]f it appears 
from the examination of such samples or otherwise that . . . such article is adulter-
ated, misbranded, or [an unapproved new drug] . . . then such article shall be refused 
admission.”119 
This statutory language clearly and unambiguously imposes a mandatory re-
quirement for the FDA to seize any and all shipments of drugs from non-registered 
facilities and detain them if it finds that they do not meet the requirements of the 
FDCA. The FDA argued its decisions were not justiciable and “the court should 
defer to its interpretation of the statute.”120 Moreover, even if, arguendo, the FDA’s 
decision was justiciable, “the court should defer to the FDA’s interpretation of the 
statute.”121 
                                                          
 109. Cook v. FDA, 733 F.3d 1, 4 (D.C. Cir. 2013). Sandoz is a German company which was producing 
sodium thiopental in its plant in Austria. 
 110. First Amended Complaint for Declaratory, Injunctive, and Other Relief at ¶¶ 89–90, Cook v. FDA, 
733 F.3d 1 (D.C. Cir. 2013) (No. 1:11-cv-00289-RJL), 2011 WL 13057711. 
 111. Cook, 733 F.3d at 1. 
 112. Id. at 6. 
 113. Id. at 4. 
 114. Id. at 3. 
 115. Id. at 4–5. 
 116. Id. at 5 (internal quotation marks omitted). 
 117. Id. 
 118. 21 U.S.C. § 381(a) (2018). 
 119. Id. 
 120. Cook, 733 F.3d at 4–5. 
 121. Id. at 5. 
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The Cook court disagreed. The plain, unambiguous meaning of the text of the 
FDCA “imposes mandatory duties upon the agency charged with its enforce-
ment.”122 The text of the statute provides that the FDA “shall” refuse admission to 
any drug shipment that “violates a substantive prohibition of the FDCA.”123 The 
court agreed with the plaintiffs that “the ordinary meaning of ‘shall’ is must.”124 
The statute “require[s] the agency to sample and examine for violations any drug 
offered for import that has been prepared in an unregistered facility.”125 In this case, 
the preparing facility was owned by Archimedes, which the FDA stipulated was not 
a registered facility.126 Moreover, the FDCA imposes a duty on the FDA to deny 
admission to any shipment that “appears to violate the substantive prohibitions of 
the FDCA.”127 The FDA stipulated that “the thiopental in these shipments ‘clearly 
appears’ to be an unapproved new drug.”128 By both refusing to examine the thio-
pental drug shipments—and by allowing the import of those shipments—the FDA 
had ignored its duty to follow the commands of the FDCA, and therefore, it violated 
the law.129 
The appeals court affirmed the ruling of the district court as to the grant of 
summary judgment and the permanent injunction against the FDA.130 However, the 
court vacated the requirement that the thiopental be returned as the district court did 
not properly join the state DOC.131 While the ruling in Cook legally precluded state 
DOCs from importing thiopental from manufacturers, that did not stop them from 
attempting to obtain the drug; states such as Arizona, Texas, and Nebraska have 
continued to purchase the drug from international sources.132 
B. Pentobarbital 
Once state DOCs realized they could no longer obtain thiopental for execu-
tions, the pressure was on to find a viable alternative. Pentobarbital, another short-
acting barbiturate, was still regularly used in for legitimate medical purposes in 
American hospitals.133 It should have been easy to procure; however, Lundbeck, the 
lone supplier of injectable pentobarbital, took umbrage at state DOC’s intention to 
transition from thiopental to pentobarbital.134 While Lundbeck’s corporate govern-
ance disagreed with the decision, they decreed they “had no way of keeping the 
                                                          
 122. Id. at 12. 
 123. Id. at 7. 
 124. Id. (internal quotations omitted). 
 125. Id. at 11. 
 126. Id. 
 127. Id. 
 128. Id. 
 129. Id. at 12. 
 130. Id. 
 131. Id. 
 132. Bowcott, supra note 108; Astrid Galvan & Justin Pritchard, Feds Confiscate Lethal-Injection 
Drugs Obtained Overseas by Arizona and Texas, U.S. NEWS (Oct. 23, 2015, 8:14 PM), https://www.us-
news.com/news/us/articles/2015/10/23/documents-arizona-tried-to-illegally-import-execution-drug. 
Arizona paid upwards of $27,000 for thiopental which was eventually seized by the FDA in July of 2015. 
Nebraska previously paid $54,400 for the same drug from Indian distributor Harris Pharma. 
 133. Greg Bluestein, Replacement Execution Drug Ample, but has Issues, WASH. POST (Mar. 2, 2011, 
3:45 PM), https://tinyurl.com/y9jesywq 
 134. David Jolly, Danish Company Blocks Sale of Drug for U.S. Executions, N.Y. TIMES (July 1, 2011), 
https://www.nytimes.com/2011/07/02/world/europe/02execute.html. 
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drug out of death chambers [because] ‘once they sell a product, they have no control 
over how it is used.’”135 Part of the issue was that, unlike thiopental, pentobarbital 
was manufactured at a plant located in Kansas.136 Given pentobarbital’s domestic 
manufacture, Lundbeck would not be able to use strict import or export rules to 
keep the drugs from being sold to state DOCs.137 
However, Lundbeck soon changed its mind. In a statement from Lundbeck’s 
chief executive, Ulf Wiinberg, the company outlined its new policy regarding drugs 
possibly used for capital punishment: a strict down-stream distribution control with 
a goal of excluding sales to state DOCs.138 “While the company has never sold the 
product directly to prisons and therefore [cannot] make guarantees, we are confident 
that our new distribution program will play a substantial role in restricting prisons’ 
access to [pentobarbital] for misuse as part of lethal injection.”139 
C.  European Corporate Morality and Abolitionist Sentiment 
Drive Shortages 
For decades, Europe has sought the world-wide abolition of the death pen-
alty.140 In fact, abolitionist sentiment is such a part of the European Union’s (“EU”) 
identity that to be admitted to the EU, a country must first ratify, among other laws, 
Protocol No. 6 to the European Convention of Human Rights,141 a piece of legisla-
tion which concerns the abolition of the death penalty.142 
The EU, after securing the abolition of the death penalty from the vast majority 
of Europe,143 set its sights on the rest of the world, including the United States.144 
Indeed, the EU touts itself as “the leading institutional actor and largest donor in the 
fight against [the] death penalty worldwide.”145 For years, the EU has attempted to 
legally influence America’s decisions on the death penalty, both directly and indi-
rectly, to no avail.146 The EU passed numerous protocols and regulations regarding 
abolition of capital punishment and attempted to encourage organizations to take 
                                                          
 135. Bluestein, supra note 133. 
 136. Id. 
 137. Id. 
 138. Press Release, Lundbeck, Lundbeck Overhauls Pentobarbital Distribution Program to Restrict 
Misuse (Jan. 7, 2011), http://investor.lundbeck.com/releasedetail.cfm?releaseid=605775. 
 139. Jolly, supra note 134. 
 140. See, e.g., Fight Against Death Penalty, EUR. COMMISSION, https://ec.europa.eu/europeaid/sec-
tors/human-rights-and-governance/democracy-and-human-rights/fight-against-death-penalty_en (last 
visited Nov. 21, 2018) [hereinafter Fight Against Death Penalty]. 
 141. Protocol No. 6 to the Convention for the Protection of Human Rights and Fundamental Freedoms 
Concerning the Abolition of the Death Penalty, opened for signature Apr. 28, 1983, E.T.S. No. 114. 
 142. Id.; see also EUROPEAN UNION, Joining the EU, https://europa.eu/european-union/about-eu/coun-
tries_en#joining_the_eu (last visited Apr. 5, 2018) (explaining that joining the EU requires accepting all 
EU legislation). 
 143. Belarus is the only remaining hold-out. Oliver Smith, Mapped: The 58 Countries That Still Have 
the Death Penalty, TELEGRAPH (July 6, 2018, 12:00 PM), http://www.telegraph.co.uk/travel/maps-and-
graphics/countries-that-still-have-the-death-penalty/. 
 144. Guidelines to EU Policy Towards Third Countries on the Death Penalty, EUR. UNION (Jun. 29, 
1998), http://www.refworld.org/docid/4705f3d12.html. 
 145. Fight Against Death Penalty, supra note 140. 
 146. See id. (providing an overview of the EU’s attempt to abolish the death penalty). 
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up the banner of abolition; however, it has had no effect on the use of capital pun-
ishment in the United States.147 The EU filed amicus briefs in capital punishment 
cases before the Supreme Court.148 Additionally, the International Court of Justice 
(“ICJ”) issued its own stay in the case of Angel Breard—a stay the Supreme Court 
ignored.149 Moreover, EU member states “refuse to extradite fugitives to retention-
ist150 states in the absence of assurances that the death penalty will not be sought.”151 
None of this legal maneuvering had any effect whatsoever, so the EU changed tac-
tics. 
The EU’s Charter of Fundamental Rights states that “[e]veryone has the right 
to life” and “[n]o one shall be condemned to the death penalty, or executed.”152 To 
that end, the EU has repeatedly proposed guidelines and policies aimed at abolish-
ing the death penalty worldwide.153 This legislation has included strict export con-
trols on drugs known to be used in capital punishment.154 
In 2005, the EU passed a regulation “ban[ning] the export and import of goods 
which can only be used to apply the death penalty.”155 However, this regulation did 
not explicitly include pharmaceuticals in the list of prohibited goods.156 Instead, it 
included items that could be used in the death chamber, such as automatic injection 
systems or electric chairs.157 This left responsibility for down-stream drug controls 
to the individual manufacturers. 
Some manufacturers, such as Lundbeck, did institute their own controls.158 
Lundbeck’s system required individual corporate authorization for every order.159 
Additionally, purchasers had to sign an agreement, averring that the pentobarbital 
they purchased was to be used exclusively in the treatment center or hospital that 
                                                          
 147. See, e.g., Moshik Temkin, The Great Divergence: The Death Penalty in the United States and the 
Failure of Abolition in Transatlantic Perspective (Harvard Kennedy Sch., Working Paper No. RWP15-
037, 2015). 
 148. See, e.g., Brief of Amici Curiae the European Union and Members of the International Community 
in Support of Respondent, Roper v. Simmons, 543 U.S. 551 (2005) (No. 03-633), 2004 WL 1619203. 
 149. David Stout, Clemency Denied, Paraguayan is Executed, N.Y. TIMES (Apr. 15, 1998), 
http://www.nytimes.com/1998/04/15/us/clemency-denied-paraguayan-is-executed.html (Breard was a 
Paraguayan citizen who was executed in Virginia in 1998. The ICJ alleged that Breard’s execution and 
detention were in violation of the Vienna Conventions as, when he was arrested, he was not notified “of 
his right to confer with Paraguayan consular officials. . . .”). 
 150. Retentionist states refer to those states that “retain” the death penalty as a legal method of punish-
ment. Abolitionist and Retentionist Countries, DEATH PENALTY INFO. CTR., https://deathpenal-
tyinfo.org/abolitionist-and-retentionist-countries (last visited Nov. 21, 2018). 
 151. Extradition, CTR. ON DEATH PENALTY WORLDWIDE, http://www.deathpenaltyworldwide.org/ex-
tradition.cfm (last updated Oct. 31, 2011). 
 152. Charter of Fundamental Rights of the European Union, tit. 1, art. 2, 2012 O.J. (C 326) 1. 
 153. Fight Against the Death Penalty, supra note 140. 
 154. Council Regulation 1236/2005, art. 5, 2005 O.J. (L 200) 1 (EC); Council Regulation 2016/2134, 
art. 7b, 2016 O.J. (L 338) 1 (EU). 
 155. Council Regulation 1236/2005, art. 5, 2005 O.J. (L 200) 1 (EC); European Commission Press 
Release IP/16/3286, EU Strengthens Trade Rules Against Goods Used for Capital Punishment and Tor-
ture (Oct. 4, 2016). 
 156. Council Regulation 1236/2005, ch. 2 art. 3, 2005 O.J. (L 200) 1 (EC). 
 157. Id. at annex II. 
 158. Lundbeck, supra note 138. Lundbeck was followed by some other manufacturers in instituting 
distribution controls. Raymond Bonner, Capital Punishment is Bad for Business, POLITICO (Apr. 28, 
2015), https://www.politico.com/magazine/story/2015/04/capital-punishment-is-bad-for-business-
117435_Page2.html. 
 159. Lundbeck, supra note 138. 
14
The Business, Entrepreneurship & Tax Law Review, Vol. 2 [2018], Iss. 2, Art. 8
https://scholarship.law.missouri.edu/betr/vol2/iss2/8
Iss. 2] Booth: Better the Devil You Know 409 
purchased it.160 Moreover, the purchaser had to agree to not re-distribute the pento-
barbital without express consent from Lundbeck.161 Such authorizations were avail-
able only to hospitals and treatment centers; any order from a prison in a state that 
carried out capital punishment would be denied.162 
In 2016, the EU tightened the noose by explicitly banning the export of phar-
maceuticals that could be used for capital punishment, including thiopental and pen-
tobarbital, to non-abolitionist countries.163 However, the ban is not absolute.164 The 
regulation sets up a complicated export authorization system, specifically “designed 
to prevent [the exported goods] from being used for capital punishment.”165 
This system requires any destination country that has not abolished capital pun-
ishment (or “confirmed that abolition through an international commitment”) be 
subject to a thorough examination prior to any export potentially capable of being 
used for capital punishment.166 Such an examination would require a risk assess-
ment regarding the likelihood “that the end-user . . . would use the exported goods 
for such punishment” and would require “appropriate conditions and requirements 
. . . be imposed to control sales or transfers to third parties by the end-user.”167 
Although much of the regulation is targeted towards destination countries that 
have not abolished capital punishment, there is language acknowledging the danger 
of export even to abolitionist countries.168 Even if the destination has abolished the 
death penalty, “there is [still] a risk of re-export to countries that have not done so 
[and] certain conditions and requirements should be imposed when authorising [sic] 
exports to countries that have abolished capital punishment.”169 Additionally, goods 
originating from non-EU territories are prohibited from travel through the EU with-
out prior authorization, as they could be destined for use in capital punishment.170 
The regulation is also forward-thinking. It explicitly states that, not only will 
exports of goods historically used for capital punishment be subject to scrutiny and 
authorization, so will “goods whose use for capital punishment [has been] approved, 
without . . . having [been] used for that purpose yet.”171 Moreover, language was 
added to create a procedure to add goods to the list, should the need arise.172 
While this type of legislation sounds good in theory, it lacks teeth. Penalties for 
violating this regulation are rare, as the EU has left it up to the individual state to 
“lay down the rules on penalties applicable to infringements of the provisions of 
                                                          
 160. Id. 
 161. Id. 
 162. Id. 
 163. Council Regulation 2016/2134, annex IIIa, 2016 O.J. (L 338) 1 (EU). The list includes “products 
containing one of the [controlled products].” 
 164. See id. at art. 7c. 
 165. Id. at preamble ¶ 3. 
 166. Id. at preamble ¶ 6 
 167. Id. 
 168. Id. at preamble ¶ 5. 
 169. Id. 
 170. Id. at art. 6a. 
 171. Id. at preamble ¶ 9. 
 172. Id. at art. 15b. 
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this Regulation and shall take all measures necessary to ensure that they are imple-
mented.”173 The only guidelines given for penalties are that they should be “effec-
tive, proportionate[,] and dissuasive.”174 
However, it is possible that the offending country could receive some form of 
sanction for violating EU law. The Court of Justice of the European Union 
(“CJEU”) exists to ensure that EU law is applied uniformly in all member states.175 
The European Commission, or any other member state, can bring an infringement 
action before the CJEU to enforce EU law.176 If the court finds  the member state 
has failed to uphold EU law, the offending state has the opportunity to correct the 
error.177 If it refuses to correct the error or it ignores the court’s judgment, the Com-
mission “may, when it deems appropriate, specify the amount of the lump sum or 
penalty payment to be paid by the Member State concerned which it considers ap-
propriate in the circumstances.”178 The court can then impose a fine up to the 
amount specified by the Commission.179 This is more of a public shaming than an 
effective sanction as the offending state has several opportunities to correct its ac-
tions prior to any true sanction being applied. 
Supreme Court decisions changed the legal landscape of the death penalty. 
While the Court has repeatedly upheld the constitutionality of lethal injection, there 
are still challenges to its implementation. Manufacturer-driven shortages have con-
tributed to a strange scenario playing out across the country—state DOCs are taking 
extreme steps to continue executions. These include attempting to import drugs il-
legally, switching up protocols to try new and untested drugs, and outright deceiv-
ing manufacturers and distributors to obtain drugs. 
While it could be argued that the choice to switch drugs without any evidence 
that they will work could create a “substantial risk of serious harm,”180 the Court 
has never agreed with that proposition. It seems that states have taken the Court’s 
refusal to side with inmates as a free pass to experiment with their execution drug 
choices, and states have proceeded, unconstrained, in their quest to continue execu-
tions. 
IV. STATE RESPONSE TO SHORTAGES 
A. Lethal Injection Drug Choice Hot Potato 
Between European manufacturers refusing to provide drugs to states for lethal 
injection purposes and the holding in Cook, leaving state DOCs scrambling for 
sources of exaction drugs. While some states decided to go back to the drawing 
                                                          
 173. Council Regulation 1236/2005, art. 17(1), 2005 O.J. (L 200) 1 (EC). 
 174. Id. For example, the United Kingdom has enacted the embargo on goods that could possibly be 
used in capital punishment. The penalties for violating the embargo include fines and possible prison 
time. See Export Control Order, 2008, SI 2008/3231, art. 6, ¶ 34 (UK). 
 175. Communication from the Commission to the European Parliament, the Council, the European 
Economic and Social Committee and the Committee of the Regions—Towards an EU Criminal Policy: 
Ensuring the Effective Implementation of EU Policies Through Criminal Law, at 9, COM (2011) 573 
final (Sept. 20, 2011). 
 176. 2012 O.J. (C 326) 47 at art. 258. 
 177. Id. at art. 259. 
 178. Id. at art. 260. 
 179. Id. 
 180. Glossip v. Gross, 135 S. Ct. 2726, 2737 (2015). 
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board to create new drug cocktails, or enact new privacy and secrecy laws, several 
states decided to attempt to import thiopental illegally.181 
In 2015, the FDA stopped a shipment of thiopental bound for Arizona.182 Ear-
lier that same year, the FDA stopped a shipment of thiopental headed for Ne-
braska.183 Arizona attempted to purchase 1,000 vials of thiopental for use in execu-
tions within the state.184 Although the shipping documents for the Arizona shipment 
were redacted, they were virtually identical to shipping documents contained in the 
Nebraska shipment.185 Both shipments seemingly came from Harris Pharma, an In-
dian supplier.186 While the Arizona DOC likely knew importing thiopental was pro-
hibited, it still filled out all the appropriate Drug Enforcement Agency (“DEA”) 
forms needed to import the drug.187 The DEA accordingly notified the FDA of the 
attempted purchase, enabling the FDA to stop the shipment before it left for its final 
destination.188 
In response to the inability to obtain thiopental, Arizona switched to using pen-
tobarbital for executions.189 Once pentobarbital also became unavailable, Arizona 
switched to a drug cocktail containing midazolam.190 However, the change to mid-
azolam was unsustainable as the botched execution of Joseph Wood in 2014  re-
sulted in a lawsuit that kept Arizona from executing anyone since.191 In response, 
Arizona concocted a novel and bizarre invitation to those on death row: bring your 
own execution drugs.192 Aside from the impossibility of going to your local drug 
store and picking up a vial of pentobarbital (or other similar drug), it is highly un-
likely that any death-row inmate would willingly hasten their own execution by 
obtaining their own execution drugs.193 
Arizona is not alone in its zealotry. In 2017, the Arkansas DOC was sued by 
McKesson, a pharmaceutical distributor, in relation to a supply of vecuronium.194                                                           
 181. Michael Kiefer, Arizona Again Tries to Illegally Import Execution Drug, AZCENTRAL, 
http://www.azcentral.com/story/news/arizona/investigations/2015/10/22/arizona-corrections-import-
thiopental-illegal-execution-drug/74406580/ (last updated Oct. 17, 2017, 7:05 PM). 
 182. Id. 
 183. Id. 
 184. Id. 
 185. Id. 
 186. Id. While neither the DOC nor the FDA confirmed Harris Pharma as the source of the thiopental, 
the redacted Arizona documents were nearly identical to documents obtained by the American Civil 
Liberties Union in relation to the attempted purchase by Nebraska. 
 187. The main issue with this attempted purchase is that thiopental cannot legally be imported as it has 
never been approved for use for any purpose by the FDA. See id. 
 188. Id. 
 189. Id. 
 190. Id. Pentobarbital became unavailable because European manufacturers instituted distribution con-
trols on drugs in connection with lethal injections. 
 191. Associated Press, Arizona Lets Death-Row Inmates Pick Their Own Execution Drugs, N.Y. POST, 
http://nypost.com/2017/02/17/arizona-lets-death-row-inmates-pick-their-own-execution-drugs/ (last up-
dated Feb. 17, 2017, 7:51 PM) [hereinafter Arizona Drugs]. See also Execution Log, supra note 2. The 
main issue in controversy is whether Arizona has abused its discretion in the type and the amount of 
drugs used during executions. 
 192. Arizona Drugs, supra note 191. 
 193. Id. 
 194. Vecuronium is a paralytic and the second drug in Arkansas’ three-drug cocktail. See Vecuronium, 
DRUGS.COM (Sept. 5, 2018), https://www.drugs.com/cdi/vecuronium.html; Ann Kenda, State’s Three-
Drug Execution Cocktail is Native to Hospital Supply Shelves, ARK. PUB. MEDIA (Apr. 3, 2017), 
http://arkansaspublicmedia.org/post/states-three-drug-execution-cocktail-native-hospital-supply-
shelves. Verified Complaint for Emergency Injunctive Relief and Return of Illegally Obtained Property 
at ¶ 13, McKesson Med.-Surgical, Inc. v. Arkansas, No. 60CV-17-1921 (Pulaski Cty., Ark. Apr. 14, 
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McKesson alleged the Arkansas DOC obtained the supply of vecuronium by mis-
representing the intended use for the drug.195 According to the complaint filed by 
McKesson, the Arkansas DOC represented that the vecuronium would be used for 
a legitimate medical purpose—namely, treatment of medical patients.196 Further, 
McKesson alleged the Arkansas DOC did all of this with the knowledge that 
McKesson did not allow sales of vecuronium to facilities that “administer capital 
punishment.”197 In fact, the Deputy Director of the Arkansas DOC, Rory Griffin, 
was aware that McKesson had such distribution controls in place, and that the sales 
agent who entered the order made a mistake in doing so.198 
Once McKesson discovered that supplies of its vecuronium had been sent to 
the DOC facility, it requested the return of the product, issued a full refund to the 
Arkansas DOC, and sent a prepaid shipping label to facilitate the return of the 
drug.199 The Arkansas DOC refused to return the drug unless McKesson would sup-
ply an alternative product for use in executions.200 In response, McKesson sought 
injunctive relief in Pulaski County Circuit Court, Arkansas, namely because the 
publication of McKesson’s involvement in this matter could cause “grave reputa-
tional harm for being associated with the planned execution of the seven inmates 
using products the manufacturer banned for such purpose.”201 McKesson requested 
the court to grant an injunction barring the Arkansas DOC from using the vecu-
ronium in the upcoming executions and also requested an order requiring the vecu-
ronium to be returned to McKesson.202 
The circuit court granted a temporary restraining order (“TRO”), finding that 
McKesson had proven both irreparable harm and a likelihood of success on the 
merits.203 The Arkansas DOC appealed, after which McKesson requested the TRO 
be vacated as a federal preliminary injunction halting the executions rendered the 
TRO moot.204 However, McKesson refiled its complaint requesting an injunction 
on April 18, 2017.205 The state court again found for McKesson and again issued a 
                                                          
2017), https://deathpenaltyinfo.org/files/pdf/Arkansas/McKessonComplaint.pdf [hereinafter McKesson 
Complaint]. 
 195. McKesson Complaint, supra note 194. This supply became the center of national news when Ar-
kansas attempted to execute eight men in ten days due to the expiration of its supply of midazolam. Only 
four men were executed; the remaining executions were stayed for various reasons. Background on Ar-
kansas April 2017 Executions, DEATH PENALTY INFO. CTR., https://deathpenaltyinfo.org/Back-
ground_on_Arkansas_April_2017_Executions (last visited Nov. 22, 2018). 
 196. McKesson Complaint, supra note 194, at ¶ 13. 
 197. Id. at ¶ 18. 
 198. Id. at ¶ 30–32. 
 199. Id. at ¶ 21–22. 
 200. Id. at ¶ 24. 
 201. Id. at ¶ 39. 
 202. Id. at ¶ 13. 
 203. Temporary Restraining Order at ¶ 3–4, McKesson Med.-Surgical, Inc. v. Arkansas, No. CV17-
1921 (Pulaski Cty., Ark. Apr. 14, 2017), https://deathpenaltyinfo.org/files/pdf/Arkan-
sas/McKessonInjunction.pdf. 
 204. McGehee v. Hutchinson, No. 4:17-CV-00179 (E.D. Ark. Mar. 27, 2017), vacated, No. 17-1804 
(8th Cir. Apr. 17, 2017). 
 205. Verified Complaint for Emergency Injunctive Relief and Return of Illegally Obtained Property, 
McKesson Med.-Surgical, Inc. v. Arkansas, No. 60CV-17-1960 (Pulaski Cty., Ark. Apr. 18, 2017), 
https://deathpenaltyinfo.org/files/pdf/Arkansas/McKessonReFiledComplaint04.18.17.pdf. 
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TRO.206 The TRO was stayed by the Arkansas Supreme Court.207 Executions com-
menced April 20, 2017, and Ledell Lee was executed with the three drug cocktail 
that included the vecuronium purchased from McKesson.208 
B. State Secrecy Laws 
In response to shortages and refusal of drug manufacturers to send execution 
drugs from Europe, states have increasingly turned to compounding pharmacies and 
concealment. In most cases, these back-room dealings are protected by an ever-
increasing litany of privacy laws that shield everyone involved, including both the 
individuals present in the execution chamber and the drug manufacturers.209 This 
secrecy is controversial. On one hand, keeping the manufacturer of the execution 
drugs a secret could facilitate obtaining the best possible drugs for the execution.210 
On the other hand, states can skirt regulations and processes that ensure safe and 
effective drugs in the name of privacy.211 Additionally, some state secrecy laws are 
being challenged on the grounds that the First Amendment gives citizens the right 
to know how prisoners are to be executed “in the name of the people.”212 
As of 2018, 24 states have laws on the books protecting at least some portion 
of the execution team.213 Twelve states have laws that explicitly protect the supplier 
of execution drugs.214 Some statutes are broader than others. For example, Ohio law 
requires the state to keep confidential the identity of any person who does the fol-
lowing: 
manufactures, compounds, imports, transports, distributes, supplies, pre-
scribes, prepares, administers, uses, or tests any of the compounding 
equipment or components, the active pharmaceutical ingredients, the drugs 
or combination of drugs, the medical supplies, or the medical equipment 
used in the application of a lethal injection of a drug or combination of 
drugs.215 
                                                          
 206. Order Granting Plaintiff’s Motion for Preliminary Injunction, McKesson Med.-Surgical, Inc. v. 
Ark., No. 60CV-17-1960 (Pulaski Cty., Ark. Apr. 20, 2017), https://deathpenaltyinfo.org/files/pdf/Ar-
kansas/McKesson_TRO_04.20.17.pdf. 
 207. Formal Order, McKesson Med.-Surgical Inc., v. Arkansas, No. CV-17-317 (Ark. Apr. 20, 2017), 
https://deathpenaltyinfo.org/files/pdf/Arkansas/McKesson-CV-17-317-ARSCTOrder.pdf. 
 208. Alan Blinder & Manny Fernandez, Arkansas Puts Ledell Lee to Death, in Its First Execution Since 
2005, N.Y. TIMES (Apr. 21, 2017), https://www.nytimes.com/2017/04/21/us/arkansas-death-penalty-le-
dell-lee-execution.html?smid=tw-share&_r=0. 
 209. See, e.g., GA. CODE ANN. §42-5-36(d)(2) (West 2017); MO. REV. STAT. § 546.720 (2007); OHIO 
REV. CODE ANN. § 2949.221 (West 2015). 
 210. See Dart, supra note 7. 
 211. Ed Pilkington & Jon Swaine, Guardian Challenges Lethal Injection Secrecy in Landmark Mis-
souri Lawsuit, GUARDIAN (May 15, 2014, 11:00 AM), https://www.theguard-
ian.com/law/2014/may/15/guardian-challenges-lethal-injection-secrecy-death-penalty-drugs. 
 212. Id. This may be the first time a challenge to state secrecy has been brought under the First Amend-
ment. 
 213. Dart, supra note 7. These states are Arizona, Arkansas, Florida, Georgia, Idaho, Indiana, Kansas, 
Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, North Carolina, Ohio, Oklahoma, Or-
egon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, and Virginia. 
 214. Dart, supra note 7. These states are Arizona, Florida, Georgia, Mississippi, Missouri, North Car-
olina, Ohio, Oklahoma, South Dakota, Tennessee, Texas, and Virginia. 
 215. OHIO REV. CODE ANN. § 2949.221(B) (West 2015). 
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This statute is incredibly broad and potentially covers every person who en-
counters the execution, or any of its component parts, in any fashion. While it would 
make sense to protect the identities of those physically present at the execution, this 
statute far overreaches that small group of individuals. 
Confidentiality in this context applies not only to informational requests, but 
also to disclosure in judicial proceedings, including “discovery, subpoena, or any 
other means of legal compulsion.”216 Ohio law does authorize disclosure to the Ohio 
ethics commission to ensure that drugs are provided in accordance with ethics laws 
and licensure requirements.217 While this is a step in the right direction, ensuring 
compliance with licensure requirements is not enough. There appears to be no 
mechanism for testing a compounded drug’s potency or quality, and such testing 
should be required for compounded lethal injection drugs.218 A pharmacy may be 
licensed to compound or provide drugs, but licensure does not ensure the adequacy 
of the drugs themselves.219 
While similar to Ohio’s statute, Georgia has gone a step further and classifies 
the source of execution drugs as a “state secret.”220 This law has been the subject of 
continuing challenges by death row inmates, and this is especially problematic 
given the Court’s decisions in Baze and Glossip regarding the necessary showing 
for a constitutional challenge.221 To be successful, the challenger must first establish 
that there is a “substantial risk of serious harm.”222 Then, the challenger must pro-
vide an alternative method that is “feasible, readily implemented, and in fact signif-
icantly reduces a substantial risk of severe pain.”223 The court will deem the method 
of execution an Eighth Amendment violation only if the challenger carries this bur-
den, and the state refuses to adopt the alternative method.224 
Georgia law has essentially made an Eighth Amendment challenge impossible 
for its death row inmates. If the inmates do not know which drugs are to be used in 
their executions, or where the drugs come from, they cannot make a showing that 
there is “substantial risk of serious harm,”225 let alone provide an alternative 
method. However, Georgia’s courts have disagreed. 
                                                          
 216. Id. § 2949.221(B)(1)-(3). 
 217. Id. § 2949.221(B)(4)(a). 
 218. See id. at § 2949.221(B) This section provides for confidentiality of any individual that tests the 
drugs, if such testing occurs. There is no statutory requirement that the drugs be tested at all. 
 219. See Press Release, FDA Office of Criminal Investigations, Outbreak was the Largest Public Health 
Crisis Ever Caused by a Pharmaceutical Product (Oct. 25, 2017), 
https://www.fda.gov/ICECI/CriminalInvestigations/ucm582187.htm; see also Ed Silverman, Safety Is-
sues at Compounding Pharmacy Underscore Oversight Problems, STAT (Apr. 8, 2016), 
https://www.statnews.com/pharmalot/2016/04/08/compounding-pharmacy-drug-safety-fda/ (this con-
cern was especially acute in 2012, when 12,000 vials of a steroid contaminated with fungal meningitis 
were shipped around the country, infecting 753 patients in 20 states, 64 of whom died). Multistate Out-
break of Fungal Meningitis and Other Infections – Case Count, CDC, https://www.cdc.gov/hai/out-
breaks/meningitis-map-large.html (last updated Oct. 30, 2015). See also discussion infra Section V.B. 
 220. GA. CODE ANN. §42-5-36(d)(2) (West 2017). 
 221. Baze v. Rees, 553 U.S. 35, 50 (2008) (requiring the inmate to show, in order to prevail on an 
Eighth Amendment claim, that the procedure entail an “objectively intolerable risk of harm.”); Glossip 
v. Gross, 135 S. Ct. 2726, 2737 (2015) (holding that “prisoners must identify an alternative that is feasi-
ble, readily implemented, and in fact significantly reduces a substantial risk of severe pain.”). 
 222. Baze, 553 U.S. at 50. 
 223. Id. at 52. 
 224. Id. 
 225. Id. at 50. 
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In Owens v. Hill,226 the Georgia Supreme Court reversed the trial court’s in-
junction in favor of inmate Warren Hill.227 The court noted that Hill was provided 
information that the drug had come from a compounding pharmacy, but there is no 
indication that Hill was provided with information about whether the drug had been 
tested for potency or contaminants.228 The court discounted Hill’s arguments re-
garding possible harm due to contaminants or potency, stating that while Hill’s 
claim of possible “side effect[s] obviously would be shockingly undesirable in the 
practice of medicine, [they are] certainly not a worry in an execution.”229 
Moreover, the court reasoned if Hill’s challenge was more colorable under the 
Baze standard, meaning that, but for the secrecy statute Hill’s claim might be mer-
itorious, then the constitutionality of the secrecy statute might legitimately be ques-
tioned.230 However, the court also voiced a reluctance to reach the constitutional 
question and stated such an analysis might be avoided by providing other forms of 
“discovery not forbidden by the execution-participant confidentiality statute.”231 
Brandon Jones mounted a challenge similar to Hill’s in 2016.232 The Georgia 
Supreme Court held that Jones did not show the Georgia statute violated his right 
to due process.233 Additionally, Jones did not show the method of execution would 
put him at a substantial risk of harm, nor did he provide a reasonably feasible alter-
native.234 While Hill may not have shown an alternative method, such a showing 
would be nearly impossible given the barrier to access of information regarding the 
state’s chosen method.235 
The Missouri secrecy statute has also been a source of debate.236 The Missouri 
statute is, at first glance, less broad than that of states such as Ohio and Georgia.237 
The statute states that no one is allowed to “knowingly disclose the identity of a 
current or former member of an execution team or disclose a record knowing that it 
could identify a person as being a current or former member of an execution 
team.”238 While one would imagine this statute to cover individuals actually present 
at the execution, it has been interpreted by both Missouri courts and the DOC much 
more broadly. 
In 2006, the identity of the man who had been overseeing Missouri executions 
for over ten years was discovered by the St. Louis Post-Dispatch.239 Alan Doerhoff, 
                                                          
 226. Owens v. Hill, 758 S.E.2d 794 (Ga. 2014). 
 227. Id. at 806. Stephanie Gallman, Georgia Executes Man Despite Disability Claim, CNN, 
https://www.cnn.com/2015/01/27/us/georgia-inmate-warren-hill-tuesday-execution/index.html (last up-
dated Jan. 28, 2015, 7:48 AM) (writing on the January 28, 2015 execution of Warren Hill). 
 228. Hill, 758 S.E.2d at 801. 
 229. Id. at 802. 
 230. Id. at 800. 
 231. Id. 
 232. Jones v. Comm’r, Ga. Dep’t of Corr., 811 F.3d 1288, 1296 (11th Cir.), cert. denied sub nom. Jones 
v. Bryson, 136 S. Ct. 998 (2016). 
 233. Id. at 1292. 
 234. Id. at 1295. 
 235. See Hill, 758 S.E.2d at 808 (Benham, J., dissenting) (stating that “the confidential inmate state 
secret statute denies Hill due process by preventing him from having a legitimate opportunity to prove 
his cruel and unusual punishment claim . . .”). 
 236. MO. REV. STAT. § 546.720 (2007). 
 237. See id. 
 238. Id. § 546.720(3). 
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who had overseen 54 executions, was deposed by Michael Taylor’s240 lawyer over 
the objection of then Governor Jay Nixon.241 The evidence adduced at the trial court 
level showed that Doerhoff was incompetent at best.242 
The district court noted inconsistencies in the state’s evidence, particularly 
where testimony conflicted with dispensary logs.243 According to testimony, the 
state “administers five grams of . . . thiopental, which is a substance that produces 
anesthesia.”244 However, dispensary logs provided during discovery were incon-
sistent with this testimony.245 The state refuted the dispensary log in a letter to the 
court, stating the following: 
Five grams are in fact used. The reference to the 2.5 grams noted in the 
drug log is not correct. The doctor and the nurse who have prepared the 
drugs for the last six executions and for plaintiff’s stayed execution con-
firm that 5 grams has been used in the last six executions and was prepared 
for plaintiff’s stayed execution.246 
The next day, the state changed its tune. It sent the court a second letter stating 
that, contrary to its previous statement, “2.5 grams of sodium pentothal was pre-
pared and used at the last execution (not 5 grams) and that 2.5 grams was prepared 
for use at the execution of plaintiff.”247 The court, in response, sent interrogatories 
to Doerhoff, still referred to as John Doe I.248 Doerhoff replied he believed he “had 
the independent authority to change the dose based on his medical judgment.”249 
Doerhoff further stated he had changed the protocols numerous times before then 
and without consulting any other individual or entity.250 Doerhoff further explained, 
“it’s not unusual for me to make mistakes . . . in terms of copying one line to another 
. . . I will sometimes transpose numbers even when I’m staring at the two num-
bers.”251 
Doerhoff testified that the individuals who administer the injections are “in the 
dark so they have a small flashlight that they’re able to quickly identify the syringes, 
make the appropriate connections and injections, disconnect, clamp the tube.”252 
                                                          
 240. Michael Taylor was executed on February 25, 2014. Tony Rizzo, Missouri Executes Michael Tay-
lor for 1989 Murder of Teenager, KAN. CITY STAR (Feb. 25, 2014, 12:54 PM), http://www.kansas-
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 241. Taylor v. Crawford, No. 05-4173-CV-C-FJG, 2006 WL 1779035, at *4 (W.D. Mo. June 26, 2006); 
Kohler, supra note 239, at 5 (plaintiff’s counsel did not know Doerhoff’s identity, the Post-Dispatch 
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The district court was, understandably, concerned with the picture Doerhoff’s tes-
timony painted of Missouri’s execution procedures.253 In light of these facts, the 
district court stayed all executions, pending approval of a new execution protocol, 
holding “Missouri’s [current] lethal injection procedure subjects condemned in-
mates to an unnecessary risk that they will be subject to unconstitutional pain and 
suffering when the lethal injection drugs are administered.”254 
So far, no circuit has recognized a right to pierce the veil of secrecy based on 
the proposition that such secrecy violates an inmate’s constitutional rights.255 The 
Fifth, Eighth, and Eleventh Circuits have all declined to side with death row inmates 
who challenged secrecy statutes the inmates say violated their substantive due pro-
cess rights.256 
V. THE BEST CHANCE FOR HUMANE LETHAL INJECTION 
A. Lessons from Medical Aid-in-Dying 
Oregon’s Death with Dignity Act allows for an individual to choose to end their 
own life with medical assistance, provided they are an Oregon resident, at least 18 
years of age, and have a terminal illness.257 While Oregon was the first state to enact 
a medical aid-in-dying statute,258 several other states have since followed suit. 
Washington,259 Vermont,260 California,261 and Colorado262 all have specific medical 
aid-in-dying statutes. Montana has legalized physician-assisted death via a state Su-
preme Court decision.263 
The drugs used in lethal injection and medical aid-in-dying are generally the 
same but the administration diverges.264 Lethal injection, as the name suggests, re-
quires an injection of lethal medication (or medications) directly into the blood-
stream, whereas medical aid-in-dying is generally accomplished by consuming the 
medications orally.265 Additionally, the patient does not take a drug cocktail, but 
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 255. Jones v. Comm’r, Ga. Dep’t of Corr., 811 F.3d 1288, 1293 (11th Cir. 2016). 
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at 1293. 
 257. OR. REV. STAT. ANN. § 127.805 (West 2017). 
 258. Oregon Death with Dignity Act: A History, DEATH WITH DIGNITY, https://www.deathwithdig-
nity.org/oregon-death-with-dignity-act-history/ (last visited Nov. 21, 2018). 
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 262. COLO. REV. STAT. ANN. § 25-48-101 (West 2016). 
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BIOSCIENCES 424 (2017), https://academic.oup.com/jlb/article/4/2/424/4265564; Kimberly Leonard, 
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instead consumes a large dose of a single barbiturate, generally secobarbital or pen-
tobarbital.266 
Drug-induced death is not new, and neither is the idea of Death with Dignity. 
The most public proponent of Death with Dignity, Dr. Jack Kevorkian, began help-
ing his patients end their own lives in 1990.267 Additionally, complications from 
medical aid-in-dying are fairly rare,268 especially compared to their lethal injection 
counterparts.269 While the same complications that exist in medical aid-in-dying 
also exist in lethal injections, they are magnified due to the addition of the paralytic 
and potassium chloride.270 Death row inmates who regain consciousness during the 
procedure will not necessarily be able to indicate their wakefulness due to the par-
alytic, and the inmate will likely suffocate before their heart stops.271 Additionally, 
the administration of the potassium chloride “may well be the chemical equivalent 
of being burned at the stake.”272 
Medical aid-in-dying shows what can be accomplished when the appropriate 
drugs are available. States should look to these aid-in-dying protocols when trying 
to determine the most humane method of execution. A single, large dose of a bar-
biturate would be the best choice for executions, as it seems to produce fewer com-
plications than the current three-drug cocktail. While executions may take longer 
without the addition of the potassium to stop the heart, they would be more humane 
and may cause less distress for witnesses than the current implementation of lethal 
injection. 
B. Compounding Pharmacies 
The biggest obstacle to implementing a lethal injection procedure with a single 
dose of barbiturate is obtaining the barbiturate itself. Given drug companies’ refusal 
to supply state DOCs with drugs, compounding pharmacies represent the best hope 
for a humane death penalty in the United States. However, any compounding phar-
macy that produces a lethal injection drug would need to be highly regulated. 
Compounding “combines, mixes, or alters ingredients of a drug to create a 
medication tailored to the needs of an individual patient.”273 While the FDA is re-
sponsible for approving new drugs, it “does not verify the safety, or effectiveness 
of compounded drugs.”274 That does not mean compounded drugs are not subject 
to any regulation; rather, regulation is left to the individual state boards of phar-
macy.275                                                           
 266. Id. 
 267. Keith Schneider, Dr. Jack Kevorkian Dies at 83; A Doctor Who Helped End Lives, N.Y. TIMES 
(June 3, 2011), http://www.nytimes.com/2011/06/04/us/04kevorkian.html. 
 268. Leonard, supra note 264. 
 269. See Riley, supra note 264. Medical aid-in-dying complications include, but are not limited to, 
nausea, vomiting, regaining consciousness, and lapsing into a coma before finally dying. 
 270. See, e.g., Austin Sarat, Robert Henry Weaver & Heather Richard, Lethal Injection Leads to the 
Most Botched Executions, DAILY BEAST (Apr. 30, 2014, 8:20 AM), https://www.thedailybeast.com/le-
thal-injection-leads-to-the-most-botched-executions. 
 271. Larry Greenemeier, Cruel and Unusual?: Is Capital Punishment by Lethal Injection Quick and 
Painless?, SCIENTIFIC AM. (Oct. 27, 2010), https://www.scientificamerican.com/article/capital-punish-
ment-by-lethal-injection/. 
 272. Glossip v. Gross, 135 S. Ct. 2726, 2781 (2015) (Sotomayor, J., dissenting). 
 273. Compounding and the FDA, supra note 12. 
 274. Id. 
 275. Id. 
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The lack of regulation has been problematic. In 2012, a Massachusetts-based 
compounding pharmacy was tied to a meningitis outbreak that resulted in the deaths 
of at least 64 people.276 The New England Compounding Center (“NECC”) manu-
factured and sold nearly 17,000 vials of preservative-free steroids that were con-
taminated with 18 different types of fungi.277 Not only did the supervisory pharma-
cist, Glenn Chin, ship drugs prior to “confirming their sterility, . . . he directed [the 
employees] to mislabel drugs to conceal this practice.”278 Additionally, Chin di-
rected employees to use expired ingredients to compound drugs.279 
Unfortunately, the NECC problem is not an outlier. In 2001, the FDA did a 
small-scale study of drugs obtained from 12 compounding pharmacies and the re-
sults were alarming.280 Of the 29 drugs tested, 10 of them failed at least one of the 
quality tests.281 Nine of the drugs “failed potency testing, some with less than 70[%] 
of their declared potency.”282 In comparison, only four out of 3,000 samples ob-
tained from drug manufacturers, and tested by the FDA, had any quality prob-
lems.283 The difference is that manufacturers are subject to federal oversight.284 
In response to the NECC contamination disaster, the government increased the 
number of regulations that applied to bulk compounders like NECC, who were es-
sentially manufacturers.285 While the FDA has had the authority to regulate manu-
facturing, compounding “falls into a gray area between state and federal over-
sight.”286 For compounding pharmacies, traditionally regulated by the states, the 
FDA’s role is more reactive than proactive.287 While the FDA can respond to issues, 
it relies on state reporting.288 To combat reporting disparities, and in response to the 
meningitis outbreak, Congress enacted the Drug Quality & Security Act (“DQSA”) 
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mislead” in a federal jury trial. Chin was sentenced to eight years in prison and restitution in an amount 
as yet undetermined. 
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REUTERS (Oct. 15, 2012, 11:05 PM), https://www.reuters.com/article/us-usa-health-meningitis-com-
pounding/insight-how-compounding-pharmacies-rallied-patients-to-fight-regulation-
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in 2013.289 The DQSA exempts traditional compounders who compound for spe-
cific patient prescriptions by or under the supervision of a licensed pharmacist.290 
Additionally, the DQSA creates a new category for “outsourcing facilities” that 
choose to register with the FDA.291 
The absence of regulations for small-scale, traditional compounders is still an 
issue, particularly when that lack of regulation works in concert with a state’s desire 
to impose the death penalty. In 2018, a journalist working for BuzzFeed News dis-
covered Missouri’s lethal injection drug supplier was a compounding pharmacy 
with an alarming record of “hazardous practices.”292 Foundation Care, referred to 
by the State of Missouri as “M7,” has provided drugs for 17 Missouri executions.293 
Foundation Care has been cited by the FDA for engaging in practices that “could 
lead to contamination of drugs, potentially putting patients at risk.”294 
When the FDA came to inspect Foundation Care in 2013, the CEO attempted 
to deny the inspectors access to the facility.295 The FDA found numerous quality 
control issues in addition to “inadequate hand-washing and questionable gloving 
practices, and they determined that a test for sterility and a common toxin had not 
been conducted since at least the previous year.”296 
After releasing the results of its inspection, the FDA sent a letter to the Missouri 
Board of Pharmacy notifying it of the FDA’s findings and stating “corrective ac-
tions can be appropriately overseen by the State.297 Additionally, the FDA is refer-
ring this matter to the Missouri State Board of Pharmacy (“BOP”) for follow-up to 
ensure appropriate corrective action is taken.”298 The same day the letter was sent 
to the Missouri BOP, Missouri executed Michael Taylor with drugs it obtained from 
Foundation Care.299 
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VI. CONCLUSION 
Focusing strictly on the process of physically executing someone, small-scale 
compounding300 likely is the best hope for a humane death penalty. While difficult 
to implement, such a solution is not unworkable. It would, however, require balanc-
ing the interests of the death row inmate, the state, and individuals tasked with ob-
taining or creating the drug cocktail used in the execution. 
Each state with an active death penalty statute could construct a pharmacy in 
its prison.301 Some prisons, including the Federal Bureau of Prisons, already have 
their own pharmacies.302 First, this solution would be cost effective. Missouri paid 
Foundation Care $7,178.88 for four vials of pentobarbital.303 In 2016, Virginia paid 
a compounding pharmacy $66,000 for enough midazolam to execute two people.304 
If a state was to compound its own execution drugs, it would likely save the 
state a significant amount of money. In 2013 and 2014, Virginia paid less than $250 
per execution for lethal injection drugs.305 In 2015, that price had risen to 
$525.14.306 Starting July 1, 2016, that price became more than $16,500 per execu-
tion under a contract the Virginia DOC made with an unnamed supplier.307 That 
price was for just one of the drugs in the three-drug cocktail, but Virginia officials 
did not specify which drug.308 In comparison, the estimated cost of injectable pen-
tobarbital at a pharmacy is $1,025.11.309 
American pharmacists do not want to participate in executions, largely because 
once the secret of which pharmacy is supplying the drugs gets out, protests and 
threats ensue.310 Moreover, many pharmacists personally oppose the death penalty, 
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viewing it as unethical.311 This fear of reprisal has led many pharmacies to back 
away from agreements they had with the DOC.312 The compounder’s fear of re-
prisal, coupled with the European drug companies’ abolitionist streak, has led to a 
shortage of lethal injection drugs, and if demand remains static, basic economic 
principles dictate the price will rise.313 
Additionally, by establishing pharmacies in prisons, the state would be able to 
ensure an availability of supply. With the ability to compound its own drugs, the 
shortage induced by European manufacturers would no longer affect the scheduling 
of executions. Moreover, if the state can compound its own execution drugs, the 
problem of which drugs to use would no longer be at issue. This means not only 
would states have readily available drugs that provide the best chance of a quick 
and relatively painless death, it would also be able to ensure the purity and potency 
of those drugs. 
However, it is not so simple. As discussed above, many pharmacists are op-
posed to providing their services in furtherance of the death penalty.314 While such 
opposition could make it difficult to find pharmacists willing to compound death 
penalty drugs, it is not impossible. Given the number of compounding pharmacies 
outed for providing death penalty drugs to state DOCs, it follows logically that state 
DOCs could find a pharmacist willing to provide their services to ensure a humane 
execution.315 
Additionally, it may be difficult to obtain the raw materials needed to com-
pound the appropriate drugs. If manufacturers are unwilling to provide drugs to state 
DOCs, they may also be unwilling to provide the raw materials for compounding 
to the same facilities, especially if the manufacturers discovered how state DOCs 
used the raw materials. 
Some protection for manufacturers and pharmacists would be necessary to en-
sure ready access to materials and personnel. However, the secrecy espoused by 
states like Missouri and Georgia,316 where even the judiciary is in the dark, will only 
lead to cutting corners and inferior drugs due to a lack of oversight. The exact mech-
anism for effecting the balance between ensuring the most humane execution pos-
sible and the protection of those involved is unclear. 
It is clear some states will go to great lengths to execute those on death row. 
For example, Texas has requested the Department of Justice grant them the ability 
to expedite death penalty appeals.317 Some states, in response to the lethal injection 
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drug shortage, are contemplating making a move away from lethal injection alto-
gether. Oklahoma, a state historically associated with experimental execution pro-
cedures, adopted nitrogen hypoxia as an alternative method of execution in 2017.318 
Despite declining public approval of the death penalty,319 officials in states that 
actively use capital punishment are unambiguously unwilling to forego executions. 
If executions are to continue in this country, states must do everything in their power 
to ensure executions are as humane as possible. Given that manufacturers are recal-
citrant in providing drugs to state DOCs, the only option for a humane death penalty 
is for states to compound their own. Otherwise, states will persist in experimenting 
in a bid to carry out executions, and the number of botched executions will continue 
to rise. 
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